Research Progress of Liquid Biopsy Based on DNA Methylation in Tumor Diagnosis and Treatment
- PMID: 39766341
- PMCID: PMC11727523
- DOI: 10.3390/biom14121634
Research Progress of Liquid Biopsy Based on DNA Methylation in Tumor Diagnosis and Treatment
Abstract
Liquid biopsy has been gradually applied to the clinical diagnosis and treatment of tumors because of its non-invasive and real-time reflection of the tumor status, as well as the convenience of sample collection, which allows the detection of primary or metastatic malignant tumors and reflects the heterogeneity of the tumors. DNA methylation, which is a type of epigenetic modification, is essential in the progression of tumors. This review introduces the common DNA methylation analysis methods and discusses their advantages and disadvantages, focusing on the new progress of DNA methylation-based liquid biopsy in tumor diagnosis and treatment.
Keywords: DNA methylation; epigenetic; liquid biopsy; tumor.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Epigenetics and CTCs: New biomarkers and impact on tumor biology.Int Rev Cell Mol Biol. 2025;392:177-198. doi: 10.1016/bs.ircmb.2024.03.002. Epub 2024 Jun 1. Int Rev Cell Mol Biol. 2025. PMID: 40287220 Review.
-
Diagnostic Power of DNA Methylation Classifiers for Early Detection of Cancer.Trends Cancer. 2020 Feb;6(2):78-81. doi: 10.1016/j.trecan.2019.12.006. Epub 2020 Feb 3. Trends Cancer. 2020. PMID: 32061307 Free PMC article.
-
Ovarian Cancer Diagnosis and Prognosis Based on Cell-Free DNA Methylation.Cancer Control. 2024 Jan-Dec;31:10732748241255548. doi: 10.1177/10732748241255548. Cancer Control. 2024. PMID: 38764160 Free PMC article. Review.
-
RNA methylation: A new promising biomaker in cancer liquid biopsy.Biochim Biophys Acta Rev Cancer. 2025 Jul;1880(3):189337. doi: 10.1016/j.bbcan.2025.189337. Epub 2025 Apr 30. Biochim Biophys Acta Rev Cancer. 2025. PMID: 40315965 Review.
-
BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: Implementation in liquid biopsy in the era of precision medicine.Clin Epigenetics. 2024 Dec 6;16(1):178. doi: 10.1186/s13148-024-01787-8. Clin Epigenetics. 2024. PMID: 39643918 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
- 82472771,82273139, 82302641/the National Natural Science Foundation of China
- 22QA1408300/Shanghai Science and Technology Committee Rising-Star Program
- 2021YNZYY02/Excellent Talents Nurture Project of Shanghai Chest Hospital
- RC-202301-130/the Talent Training Plan of Shanghai Chest Hospital in 2022
- LHPD2304/High-level Local University Construction - Shanghai Jiao Tong University School of Medicine of Linghang pandeng Program
LinkOut - more resources
Full Text Sources
Medical